[Dermatologic indications for anti-androgenic treatment].

The document discussed the use of gestagens with antiandrogenic activity, often combined with estrogen, for treating conditions like oily seborrhea, acne, Fox-Fordyce disease, androgenetic alopecia, and hirsutism. Despite their effectiveness, many dermatologists were hesitant to use hormonal treatments due to misconceptions about these conditions being purely hormonal disorders. The document clarified that androgen-dependent skin disorders are not caused by endocrine disturbances but can be managed by leveraging the sebosuppressive effects of female hormones. It emphasized that antiandrogenic treatment for conditions like androgenetic alopecia and hirsutism, which involve increased androgen production, is a quasi-etiological therapy. The document advocated for dermatologists, in collaboration with endocrinologists and gynecologists, to manage these treatments and provided guidance on the appropriate use of available drugs.